OECD Science, Technology and Industry Policy Papers

ISSN :
2307-4957 (en ligne)
DOI :
10.1787/23074957
Cacher / Voir l'abstract
The OECD Directorate for Science, Technology and Innovation (STI) develops evidence-based policy advice on the contribution of science, technology and industry to well-being and economic growth. STI Policy Papers cover a broad range of topics, including industry and globalisation, innovation and entrepreneurship, scientific R&D and emerging technologies. These reports are officially declassified by an OECD Committee.
 

Workshop on Integrating Omics and Policy for Healthy Ageing

Synthesis Report You or your institution have access to this content

Anglais
Cliquez pour accéder: 
    http://oecd.metastore.ingenta.com/content/5jzb0z52dc5c.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/science-and-technology/workshop-on-integrating-omics-and-policy-for-healthy-ageing_5jzb0z52dc5c-en
  • LIRE
Auteur(s):
OCDE
Date de publication
24 jan 2014
Bibliographic information
N°:
12
Pages
21
DOI
10.1787/5jzb0z52dc5c-en

Cacher / Voir l'abstract

The increase in the human life span is a testament to the economic, social and medical progress made over the course of the last century. However, an ageing population brings some new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases. But the development of these new technologies will not be without challenges, in particular with respect to the difficulty of translating technological advances into innovation in the clinical setting. This report provides a synthesis of a March 2013 workshop organised by the OECD and the Human Genome Organisation (HGO) which focused on latest advances in omics technologies for healthy ageing and the policies and practices needed to facilitate their responsible development and integration in medical research, innovation and health policy.